Decreased heme oxygenase (HO) - 1 in induced sputum of smokers with chronic obstructive pulmonary disease (COPD)

G. Guarnieri, Y. Nowicki, S. Menato, E. Marian, P. Boschetto, C. Mapp, P. Maestrelli (Padova, Ferrara, Italy)

Source: Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Session: Markers, mediators and mechanisms of human lung injury
Session type: Thematic Poster Session
Number: 620
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Guarnieri, Y. Nowicki, S. Menato, E. Marian, P. Boschetto, C. Mapp, P. Maestrelli (Padova, Ferrara, Italy). Decreased heme oxygenase (HO) - 1 in induced sputum of smokers with chronic obstructive pulmonary disease (COPD). Eur Respir J 2003; 22: Suppl. 45, 620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009


Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH)
Source: Eur Respir J 2001; 18: Suppl. 33, 83s
Year: 2001

Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

Measurement of improved activities after pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 223s
Year: 2001

Concentration of NO2-, a-acid protein (AAP), tumor necrotic factor (TNF-a), in the induced sputum of patients with bronchial asthma(BA) and chronic obstructive bronchitis (COB)
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001

Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002

Angiopoietins in sputum supernatant of patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Changes of active expiration respiratory muscle (RM) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Respiratory and skeletal muscle assessment in health and disease
Year: 2011


Haptoglobin (Hp) phenotypes and smoking history in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 260s
Year: 2002

Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 194s
Year: 2001

CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005


Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015

Carboxyhemoglobin (COHb) and bilirubin levels increase with acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016